Verdad Advisers »

Aclaris Therapeutics shares owned by Verdad Advisers

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $739k 197k 3.75

More positions owned by Verdad Advisers

Belite Bio Sponsored Ads (BLTE)
State Street Corporation (STT)
Autohome Sp Ads Rp Cl A (ATHM)
Revolution Medicines (RVMD)
Zymeworks Del (ZYME)
Cal Maine Foods Com New (CALM)
Zoom Communications Cl A (ZM)
California Res Corp Com Stock (CRC)
Tenax Therapeutics Com New (TENX)
ACADIA Pharmaceuticals (ACAD)
Par Pac Holdings Com New (PARR)
Johnson & Johnson (JNJ)
Micron Technology (MU)
Nurix Therapeutics (NRIX)
Comcast Corp Cl A (CMCSA)

View all positions for Verdad Advisers

Top funds holding Aclaris Therapeutics

BML Capital Management
Deep Track Capital
BlackRock
RA Capital Management
Vivo Capital
Vanguard Capital Management
Frazier Life Sciences Management
Rock Springs Capital Management
Decheng Capital
Adage Capital Partners GP
Balyasny Asset Management
Citadel Advisors
Morgan Stanley
Geode Capital Management
State Street Corporation

View all funds holding Aclaris Therapeutics